Coldspot-guided antibody discovery (a screening approach that focuses on portions of the SARS-CoV-2 spike glycoprotein that are both functionally relevant...
The coronavirus keeps evolving, and in so doing it evades our immune defenses. But does the entire coronavirus evolve, or do some portions remain unchanged?...
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that The post Nine for 2023, part three:...
Biotech Vaxxas has announced a partnership agreement with the 2017-established Coalition for Epidemic Preparedness Innovations (CEPI), in order The post...
Waiting until the very last minute, former US Commerce Secretary Wilbur Ross’ special purpose acquisition company has found a business to buy: a biotech...
Ben Hargreaves speaks to Liberate Bio, a company that is hoping to address the delivery issues that could The post Taking an ‘upside-down’ approach...
Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine The post US eyes link...
Rats and mice have been the backbone of biomedical research for decades — including research to understand cancer and pioneer new treatments. Credit:...
Crossing the blood-brain barrier is a familiar challenge in therapeutic applications. And it is increasingly recognized as a challenge for imaging applications,...
At a recent industry event, the 14th Annual Bioprocessing Summit in Boston, scientists discussed a variety of advances in gene therapy manufacturing. To...
Hot penny stocks to watch with news this week. The post 5 Hot Penny Stocks To Watch This Week With Big News appeared first on Penny...
Insilico Medicine (“Insilico”), a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, held the launch ceremony...
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine (“Insilico”), a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery...
Catherine Isted has stepped down as chief executive of UK biotech ReNeuron with immediate effect, with board member The post Restructuring announced at...
Lithuania offers a range of government support for biotech companies, including 20 years of corporate tax relief for capital investments and seven Free...
There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T The post After a slow start for expensive...
It seems like a slam dunk. Why not repurpose already approved or well-studied drug candidates for conditions where treatments are desperately needed? Wouldn’t...
A review of the latest executive moves in the pharma industry over the past several months.
A deal to take Seattle biotech company Intrinsic Medicine public via a SPAC merger has fallen apart. The SPAC deal, announced in October, would have taken...
FOR RELEASE AT: Thursday, December 1, at 2 p.m. US ET Credit: UNC School of Medicine FOR RELEASE AT: Thursday, December 1, at 2 p.m. US...
In its third quarter report, Oncorus highlighted that it would report updated Phase I data on its lead candidate, an oncolytic virus therapy for solid...
Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of The post mRNA can deliver universal flu vaccine,...
Daiichi Sankyo shut down its South San Francisco subsidiary Plexxikon earlier this year. Now a new startup is looking to forge its own path — with...
The COVID-19 pandemic stopped the world in its tracks. It provided a range of new challenges for industry The post Overcoming the challenges of developing...
CytoDyn Inc (OTCMKTS: CYDY) has formed a solid base over $0.30 and is beginning to move northbound again. The stock recently made a solid bounce from...
Researchers at the University of Texas at Arlington, in collaboration with Shani Biotechnologies, a local firm, have created a point-of-care device that...
A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 million grant from the National Cancer Institute at the...
This year, with Nasdaq iced over, everything is falling behind. A quick turn to CDER’s approvals for the year reveals that the group has stamped an...
During Chardan's recent 6th Annual Genetic Medicines Conference in New York, held in-person for the first time since the COVID-19 pandemic, leaders from...
In the near future, painful jabs and muscle soreness that persists for days could be replaced by new immunization approaches including intradermal delivery,...